Jianjun Zhang

4PUBLICATIONS
30CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modellingChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 16, 2024
Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization.

Yue Jiang, Ying Yuan, Guanglei Qiao

|Dec 05, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001.

Yan Zhou, Qingcheng Yang, Yang Dong

|Jan 12, 2017
Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221.

Jianjun Zhang, Jingjing Sha, Yan Zhou

Pageof 1